JAYID's CEO, Nanako Akiyoshi, has been appointed as an external committee member for the ethics review board of a company developing technology to regenerate parts of the body lost or damaged due to illness, injury, or aging. Regenerative medicine holds immense potential to revolutionize future healthcare. However, precisely because of its advanced nature, strict ethical considerations are indispensable to gain social acceptance and trust. In this cutting-edge field, where active discussions are ongoing within the medical sector, Ms. Akiyoshi will leverage her expertise in public relations and communications. As an external committee member, she will offer objective and multifaceted perspectives to review ethical considerations and provide her insights. She is committed to contributing to the healthy development of this advanced technology and fostering dialogue between it and society.